HKEX:1582 stock news
This page provides real-time market news, earnings updates, and company announcements related to CR Construction Group Holdings Limited (HKEX:1582).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-27 04:06 HKT
Caterpillar partners with Nvidia to integrate AI technology into its construction machinery
101 finance2026-01-07 17:21:15
Crane (CR) Q4 Earnings Preview: Key Points to Watch
101 finance2026-01-25 03:12:29
Big Tech earnings and the Fed meeting headline the busiest week of the first quarter as January draws to a close: Key events to monitor
101 finance2026-01-25 12:57:31
Crane’s Fourth Quarter Earnings Call: The Five Key Analyst Questions
101 finance2026-02-02 09:30:33
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
Finviz2026-02-18 12:33:42
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Finviz2026-02-18 13:24:36
Deere lifts full-year profit forecast on construction, sales recovery; shares up
101 finance2026-02-19 11:52:27
Cassava Announces Closure of U.S. Department of Justice Investigation
Finviz2026-02-19 13:06:40
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Finviz2026-02-23 22:09:43
Protara's Experimental Bladder Cancer Drug Shows Encouraging Results
Finviz2026-02-24 12:45:12
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Finviz2026-02-25 13:00:55
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Crescent Biopharma Inc recently disclosed that certain revenues recognized in its 2025 financial report actually originate from a $20 million upfront payment made by Kelun-Biotech under a licensing agreement between the two parties for the core asset Cr-001.
老虎证券2026-02-26 13:00:08
Sarepta Drops 8.9%: The Biotech Sector's Unpredictable Journey Through Innovation and Risk
101 finance2026-02-26 15:31:26
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
Finviz2026-02-18 12:33:42
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Finviz2026-02-18 13:24:36
Deere lifts full-year profit forecast on construction, sales recovery; shares up
101 finance2026-02-19 11:52:27
Cassava Announces Closure of U.S. Department of Justice Investigation
Finviz2026-02-19 13:06:40
Ficerafusp Alfa 2000mg Q2W Demonstrates Deep, Durable Responses in 1L R/M HPV-Negative HNSCC and Supports Development of Less Frequent Dosing Regimen
Finviz2026-02-19 21:36:38
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Finviz2026-02-23 22:09:43
Protara's Experimental Bladder Cancer Drug Shows Encouraging Results
Finviz2026-02-24 12:45:12
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Finviz2026-02-25 13:00:55
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-02-26 12:33:48
Crescent Biopharma Inc recently disclosed that certain revenues recognized in its 2025 financial report actually originate from a $20 million upfront payment made by Kelun-Biotech under a licensing agreement between the two parties for the core asset Cr-001.
老虎证券2026-02-26 13:00:08
Sarepta Drops 8.9%: The Biotech Sector's Unpredictable Journey Through Innovation and Risk
101 finance2026-02-26 15:31:26
HKEX:1582 stock price change
On the last trading day, HKEX:1582 stock closed at 0.36 HKD, with a price change of 0.00% for the day.
Trade stock perpsHKEX:1582 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more